Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care Approval marks the twelfth ...
MajesTEC-9 is the second positive Phase 3 study to support TECVAYLI ® regimens as a potential new standard of care as early as first relapse RARITAN, N.J., Jan. 14, 2026 /PRNewswire/ -- Johnson & ...
The city of Dallas will equip 100 bulky trash collection trucks with AI-enabled cameras that will help city code compliance employees detect potential violations sooner. The Dallas City Council is set ...
UPDATE! Here's the Indigo Disk Update: <a href="https://youtu.be/SNqE0RFR-xQ">https://youtu.be/SNqE0RFR-xQ</a> Democrats achieved the worst of all worlds with their ...
An aardvark works in an office typing at a desktop PC while happy human workers mill about in the background. Credit: VentureBeat made with ChatGPT Positioned as a scalable defense tool for modern ...
From nanofiber filters to AI-driven diagnostics, smart respiratory protection is transforming traditional masks into connected, data-rich systems that monitor both air quality and worker health across ...
Among the earliest signs that the second Trump administration might be precipitously different from the first were the masks. Almost the first thought I had, in watching videos of federal agents ...
Abstract: 3D mask presentation attack detection is crucial for protecting face recognition systems against the rising threat of 3D mask attacks. While most existing methods utilize multimodal features ...
Google Colab, also known as Colaboratory, is a free online tool from Google that lets you write and run Python code directly in your browser. It works like Jupyter Notebook but without the hassle of ...
100 percent of evaluable patients achieved minimal residual disease (MRD) negativity following induction therapy in updated results from the Phase 2 MajesTEC-5 study "Exploring TECVAYLI, with its ...
100 percent of evaluable patients achieved minimal residual disease (MRD) negativity following induction therapy in updated results from the Phase 2 MajesTEC-5 study TORONTO, Sept. 19, 2025 ...